{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T02:03:34Z","timestamp":1788401014473,"version":"build-2803163510"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.ejphar.2017.07.019","type":"journal-article","created":{"date-parts":[[2017,7,8]],"date-time":"2017-07-08T06:34:35Z","timestamp":1499495675000},"page":"104-112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Synergistic inhibition of A\u03b2 production by combinations of \u03b3-secretase modulators"],"prefix":"10.1016","volume":"812","author":[{"given":"Alan S.","family":"Robertson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence G.","family":"Iben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Jere E.","family":"Meredith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter M.","family":"Drexler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martyn","family":"Banks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory D.","family":"Vite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard E.","family":"Olson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorin A.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles F.","family":"Albright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael K.","family":"Ahlijanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy H.","family":"Toyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2017.07.019_bib1","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1124\/jpet.104.075408","article-title":"Dynamics of \u03b2-amyloid reductions in brain, cerebrospinal fluid, and plasma of \u03b2-amyloid precursor protein transgenic mice treated with a \u03b3-secretase inhibitor","volume":"312","author":"Barten","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2017.07.019_bib2","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/978-1-61779-080-5_34","article-title":"Analysis of drug interactions","volume":"731","author":"Bijnsdorp","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ejphar.2017.07.019_bib3","doi-asserted-by":"crossref","first-page":"11810","DOI":"10.1074\/jbc.M111.305227","article-title":"First and second generation \u03b3-secretase modulators (GSMs) modulate amyloid-\u03b2 (A\u03b2) peptide production through different mechanisms","volume":"287","author":"Borgegard","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2017.07.019_bib4","doi-asserted-by":"crossref","first-page":"7389","DOI":"10.1021\/acs.jmedchem.5b01960","article-title":"Gamma secretase modulators: New Alzheimer's drugs on the horizon?","volume":"59","author":"Bursavich","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2017.07.019_bib5","doi-asserted-by":"crossref","first-page":"e83096","DOI":"10.1371\/journal.pone.0083096","article-title":"Turnover of C99 is controlled by a crosstalk between ERAD and ubiquitin-independent lysosomal degradation in human neuroglioma cells","volume":"8","author":"Bustamante","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ejphar.2017.07.019_bib6","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors","volume":"22","author":"Chou","year":"1984","journal-title":"Adv. Enzym. Regul."},{"key":"10.1016\/j.ejphar.2017.07.019_bib7","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1021\/cn200098p","article-title":"Piperidine acetic acid based \u03b3-secretase modulators directly bind to presenilin-1","volume":"2","author":"Crump","year":"2011","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejphar.2017.07.019_bib8","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1021\/bi400377p","article-title":"Development and mechanism of \u03b3-secretase modulators of Alzheimer's disease","volume":"52","author":"Crump","year":"2013","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejphar.2017.07.019_bib9","doi-asserted-by":"crossref","first-page":"37181","DOI":"10.1074\/jbc.C111.276972","article-title":"Novel \u03b3-secretase enzyme modulators directly target presenilin protein","volume":"286","author":"Ebke","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2017.07.019_bib10","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1021\/cn3000857","article-title":"Discovery of a novel pharmacological and structural class of gamma secretase modulators derived from the extract of Acteae racemosa","volume":"3","author":"Findeis","year":"2012","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejphar.2017.07.019_bib11","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/B978-0-444-63380-4.00003-2","article-title":". \u03b3-Secretase modulators: current status and future directions","volume":"53","author":"Hall","year":"2014","journal-title":"Prog. Med. Chem."},{"key":"10.1016\/j.ejphar.2017.07.019_bib12","doi-asserted-by":"crossref","first-page":"e30484","DOI":"10.1371\/journal.pone.0030484","article-title":"Presenilin is the molecular target of acidic \u03b3-secretase modulators in living cells","volume":"7","author":"Jumpertz","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ejphar.2017.07.019_bib13","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.1096\/fj.12-225649","article-title":"Steroids as \u03b3-secretase modulators","volume":"27","author":"Jung","year":"2013","journal-title":"FASEB J."},{"key":"10.1016\/j.ejphar.2017.07.019_bib14","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/nrd3505","article-title":"The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics","volume":"10","author":"Karran","year":"2011","journal-title":"Nat. Rev. Drug Disc"},{"key":"10.1016\/j.ejphar.2017.07.019_bib15","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1124\/jpet.112.192625","article-title":"Cerebrospinal fluid amyloid-\u03b2 (A\u03b2) as an effect biomarker for brain A\u03b2 lowering verified by quantitative preclinical analyses","volume":"342","author":"Lu","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2017.07.019_bib16","unstructured":"Marcin, L.R., Higgins, M.A., Lentz, K.A., Grace, J.E., Toyn, J.H., Olson, R.E., Albright, C.F., Macor, J.E., Thompson, L.A., 2012. Bicyclic triazoles as modulators of \u03b3-secretase for the treatment of Alzheimer\u2019s disease, MEDI-9, In: 243th ACS National Meeting, San Diego, California."},{"key":"10.1016\/j.ejphar.2017.07.019_bib17","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1523\/JNEUROSCI.4264-11.2012","article-title":"Differential effects between \u03b3-secretase inhibitors and modulators on cognitive function in amyloid precursor protein-transgenic and nontransgenic mice","volume":"32","author":"Mitani","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2017.07.019_bib18","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/toxsci\/kft224","article-title":"E2012-induced cataract and its predictive biomarkers","volume":"137","author":"Nakano-Ito","year":"2013","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.ejphar.2017.07.019_bib19","doi-asserted-by":"crossref","first-page":"4815","DOI":"10.1038\/emboj.2011.372","article-title":"Phenylpiperidine-type \u03b3-secretase modulators target the transmembrane domain 1 of presenilin 1","volume":"30","author":"Ohki","year":"2011","journal-title":"EMBO J."},{"key":"10.1016\/j.ejphar.2017.07.019_bib20","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1074\/jbc.M708754200","article-title":"Generation of A\u03b238 and A\u03b242 is independently and differentially affected by familial Alzheimer disease-associated presenilin mutations and \u03b3-secretase modulation","volume":"283","author":"Page","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2017.07.019_bib21","doi-asserted-by":"crossref","first-page":"9710","DOI":"10.1074\/jbc.M112.398602","article-title":". \u03b3-Secretase modulator (GSM) photoaffinity probes reveal distinct allosteric binding sites on presenilin","volume":"288","author":"Pozdnyakov","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2017.07.019_bib22","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1016\/j.bmcl.2007.04.082","volume":"17","author":"Prasad","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejphar.2017.07.019_bib23","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1750-1326-7-61","article-title":"Modulation of \u03b3-secretase by EVP-0015962 reduces amyloid deposition and cognitive deficits in Tg2576 mice","volume":"7","author":"Rogers","year":"2012","journal-title":"Mol. Neurodegen."},{"key":"10.1016\/j.ejphar.2017.07.019_bib24","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1124\/jpet.116.232256","article-title":"The \u03b3-secretase modulator, BMS-932481, modulates A\u03b2 peptides in the plasma and cerebrospinal fluid of healthy volunteers","volume":"358","author":"Soares","year":"2016","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2017.07.019_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.106.104117","article-title":"An overview of drug combination analysis with isobolograms","volume":"319","author":"Tallarida","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2017.07.019_bib26","first-page":"210756","article-title":"Modulation of gamma-secretase for the treatment of Alzheimer's disease","volume":"2012","author":"Tate","year":"2012","journal-title":"Int. J. Alzheimer Dis."},{"key":"10.1016\/j.ejphar.2017.07.019_bib27","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1124\/jpet.116.232249","article-title":"Robust translation of \u03b3-secretase modulator pharmacology across preclinical species and human subjects","volume":"358","author":"Toyn","year":"2016","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2017.07.019_bib28","first-page":"431858","article-title":"Identification and preclinical pharmacology of the \u03b3-secretase modulator BMS-869780. Int","volume":"2014","author":"Toyn","year":"2014","journal-title":"J. Alzheimer Dis."},{"key":"10.1016\/j.ejphar.2017.07.019_bib29","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/ncomms1129","article-title":"Substrate docking to \u03b3-secretase allows access of \u03b3-secretase modulators to an allosteric site","volume":"1","author":"Uemura","year":"2010","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2017.07.019_bib30","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1750-1326-6-15","article-title":"Reciprocal relationship between APP positioning relative to the membrane and PS1 conformation","volume":"6","author":"Uemura","year":"2011","journal-title":"Mol. Neurodegen."},{"key":"10.1016\/j.ejphar.2017.07.019_bib31","doi-asserted-by":"crossref","first-page":"e7893","DOI":"10.1371\/journal.pone.0007893","article-title":"Allosteric modulation of PS1\/\u03b3-secretase conformation correlates with amyloid \u03b242\/40 ratio","volume":"4","author":"Uemura","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2017.07.019_bib32","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1039\/c29700000071","article-title":"Structure of antibiotic X-537A","volume":"1970","author":"Westley","year":"1970","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejphar.2017.07.019_bib33","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/35102591","article-title":"A subset of NSAIDs lowers amyloidogenic A\u03b242 independently of cyclooxygenase activity","volume":"414","author":"Weggen","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2017.07.019_bib34","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0003-9861(64)90184-5","article-title":"Studies on liver alcohol dehydrogenase complexes","volume":"106","author":"Yonetani","year":"1964","journal-title":"Arch. Biochem. Biophys."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299917304570?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299917304570?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,30]],"date-time":"2018-08-30T12:51:08Z","timestamp":1535633468000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299917304570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":34,"alternative-id":["S0014299917304570"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2017.07.019","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synergistic inhibition of A\u03b2 production by combinations of \u03b3-secretase modulators","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2017.07.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}